Breakpoint Therapeutics Company Contacts

By targeting the DNA damage response (“DDR”) in cancer cells, Breakpoint Therapeutics aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance pathways. Our mission is to develop drugs that succeed and complement... Read More